Timothy M. Murphy, Patent Group Co-Chair
Brings prosecution skills to bear in defending companies’ rights in innovation and discovery. Prosecution involves IV delivery systems, blood processing equipment, surgical instruments, diagnostic equipment, and pharmaceuticals. Experience with patent litigation and interferences relating to pharmaceuticals and medical devices.
W. John Keyes, Ph.D., J.D.
Dr. Keyes is a patent lawyer associate at Sunstein and represents clients in a broad range of patent, intellectual property and business matters. He develops strategies to optimize the value of his client’s patent portfolios and handles post-grant proceedings before the PTAB. He also prosecutes patent applications in the chemical, pharmaceutical, biological, diagnostic, and material science arts. Dr. Keyes also counsels clients concerning patentability, validity, infringement, and freedom to operate. He has represented companies in a broad range of industries including biological medical products, stem cell therapies, bioinformatics, petrochemicals, polymers, agrochemicals, industrial processes, nanotechnologies, batteries, ceramic materials, semiconductor fabrication, power systems, new materials, software, fuel cells, and LED’s.
Bruce D. Sunstein, Founding Partner
Combines expertise in patent protection with formulating sound business strategy. Has prosecuted in the fields of neuromedical measurement devices, surgical instruments, ultrasonic bone densitometers, infusion pumps, gene expression assays and indices, and polysaccharide-based compositions and methods.
Robert M. Asher, Patent Group Co-Chair
Leads patent prosecution and enforcement, including reexaminations and litigation in areas such as medical equipment, surgical methods, and pharmaceuticals.
Kathryn E. Noll, M.S. Materials Engineering, J.D.
Prosecutes patents and counsels clients on strategic issues relating to their portfolios involving a wide array of technologies including pharmaceuticals, medical devices, diagnostic equipment, chemical processes, and nanotechnology.
Christopher Lacenere, Ph.D.
Christopher is a patent agent at Sunstein who concentrates his practice in biotech and life sciences and has particular experience in the fields of immunology, cellular and molecular biology, biochemistry, and diagnostics. In assisting clients to develop robust patent portfolios, Christopher draws on his experience developing sophisticated analysis of complex patent portfolios in litigations. He is a registered to practice as a Patent Agent before the United States Patent and Trademark Office.
Life Science Litigation, Trademark and Business Practice Leaders
Kerry Timbers, Litigation Group Co-Chair
Patent litigation leader with experience in strategic direction of life sciences litigation matters, including in areas such as pharmaceuticals, dialysis machines, electrochemical medical diagnostic devices, surgical methods, and intravenous valves and equipment.
Lisa M. Tittemore, Trademark Group Chair, Litigation Group Co-Chair
Patent, trademark and copyright litigator with extensive experience in the development, management and enforcement of the trademark portfolios of local and global biotechnology and pharmaceutical companies. Lisa writes and lectures on the topic of pharmaceutical trademarks, including regarding the interplay of USPTO and FDA procedures, and is a member of the UK-based Pharmaceutical Trademarks Group (PTMG).
Thomas C. Carey, Business Group Chair
Tom has negotiated license agreements for large pharmaceutical companies, engineered the licensing, purchase and sale of patents for large and small companies (including on an anonymous basis), counseled overseas investors on tax-efficient structures for establishing research and development facilities in the US, and counseled inventors seeking to commercialize their life sciences discoveries. He has written several articles about patent litigation involving generic challenges to pharmaceutical patents.